| COVID-19 mild to moderate | COVID-19 severe or critically | ||
| COVID 19 hospitalized | COVID-19 mild to moderate | COVID-19 severe or critically | |
| ivermectin | Khan Soto-Becerra Spoorthi Gonzalez ... ICON | Shahbaznejad Khan Kirti I-TECH ... Babalola Mayer Soto-Becerra RIVET-COV ... Ahmed Spoorthi Chachar Glorial F Chaccour Abd-Elsalam Espitia-Hernandez Bukhari Krolewiecki | Camprubi Galan Galan Okumuş |
| ivermectin plus doxycycline | Hashim A | NCT04523831 ... |
| 6083 | IFORS (Pott-Junior), 2020 | 2 | 1 | 3 | excluded | high risk of bias | |
| 6096 | Elgazzar - treatment, 2020 | 2 | 1 | 3 | excluded | high risk of bias | |
| 6368 | Niaee (vs placebo), 2020 | 2 | 1 | 3 | excluded | high risk of bias | |
| 6375 | Cadegiani -Iver, 2020 | 2 | 99 | 0 | excluded | not a RCT | risk of bias not avaialble |
| 6625 | Nasir, 2020 | 2 | 31 | 0 | excluded | not a RCT | risk of bias not avaialble |
| 7995 | Hazan, 2021 | 2 | 32 | 0 | excluded | not a RCT | risk of bias not avaialble |
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
